We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDR
12976
DELISTED
Blonder Tongue Laboratories Inc
BDR
$75K ﹤0.01%
56,871
-31,028
-35% -$38.1K
IFMK
12977
DELISTED
iFresh Inc. Common Stock
IFMK
$75K ﹤0.01%
53,331
-26,992
-34% -$37.3K
AEHR icon
12978
Aehr Test Systems
AEHR
$4.37B
$74K ﹤0.01%
+26,917
New +$64.4K
BTG icon
12979
CALL
B2Gold
BTG
$6.8B
$74K ﹤0.01%
17,600
-61,300
-78% -$299K
RKTO
12980
Rocket One Inc
RKTO
$19M
$74K ﹤0.01%
1,856
-1,334
-42% -$52.2K
TGS icon
12981
CALL
Transportadora de Gas del Sur
TGS
$4.23B
$74K ﹤0.01%
15,900
-3,300
-17% -$15.8K
VOLT
12982
CALL
DELISTED
Volt Information Sciences, Inc.
VOLT
$74K ﹤0.01%
16,300
+3,600
+28% +$14.4K
SRAX
12983
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$74K ﹤0.01%
13,558
-63,768
-82% -$307K
CRVS icon
12984
PUT
Corvus Pharmaceuticals
CRVS
$1.24B
$73K ﹤0.01%
27,500
-24,700
-47% -$68K
CTRM icon
12985
CALL
Castor Maritime
CTRM
$22.5M
$73K ﹤0.01%
+2,820
New +$115K
GNSS icon
12986
PUT
Genasys
GNSS
$78.8M
$73K ﹤0.01%
13,300
-5,000
-27% -$30.5K
IRIX icon
12987
CALL
IRIDEX
IRIX
$14.6M
$73K ﹤0.01%
+10,400
New +$79K
LWAY icon
12988
Lifeway Foods
LWAY
$396M
$73K ﹤0.01%
14,161
-2,491
-15% -$13K
JXG
12989
JX Luxventure
JXG
$73K ﹤0.01%
+32
New +$65.2K
FRES
12990
DELISTED
Fresh2 Group Limited American Depositary Shares
FRES
$73K ﹤0.01%
86
-40
-32% -$38K
NBSE
12991
PUT
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$73K ﹤0.01%
+760
New +$84K
MDNA
12992
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$73K ﹤0.01%
+24,203
New +$89.5K
BNSO
12993
DELISTED
Bonso Electronic International
BNSO
$73K ﹤0.01%
10,633
-388
-4% -$2.61K
BIOR
12994
PUT
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$73K ﹤0.01%
+82
New +$62.7K
ELOX
12995
CALL
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$73K ﹤0.01%
+923
New +$77K
NAVB
12996
CALL
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$73K ﹤0.01%
40,100
+7,200
+22% +$12.7K
MACK
12997
PUT
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$73K ﹤0.01%
11,500
-59,400
-84% -$392K
HYPD
12998
PUT
Hyperion DeFi Inc
HYPD
$41.2M
$72K ﹤0.01%
+181
New +$74.4K
GTIM icon
12999
Good Times Restaurants
GTIM
$16.6M
$72K ﹤0.01%
17,516
+41
+0.2% +$178
RDI icon
13000
Reading International Class A
RDI
$37.9M
$72K ﹤0.01%
10,399
-9,651
-48% -$61K

Similar funds

Citadel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Citadel Advisors held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Citadel Advisors's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Citadel Advisors's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Citadel Advisors added most to AT&T in Q2 2021, an estimated $877M increase.
  • Citadel Advisors's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Citadel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Citadel Advisors's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Citadel Advisors opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Citadel Advisors's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.